BPC-157

BPC-157 (Body Protection Compound-157) is a synthetic peptide of 15 amino acids. Its sequence corresponds to a partial fragment of a cytoprotective protein originally isolated from human gastric juice, which is where the "body protection compound" name comes from.

Unlike many peptides, BPC-157 is reported in the literature to be stable in gastric acid, which is part of why it has drawn sustained research interest as a model compound for studying tissue protection and repair.

In preclinical and animal-model research, investigators have examined BPC-157 in the context of angiogenesis (new blood-vessel formation), growth-factor signaling, and nitric-oxide pathways. A frequently cited line of research explores its interaction with the VEGFR2 receptor and downstream vascular effects.

These are mechanistic observations reported in laboratory studies. They describe what researchers have measured in controlled models, not outcomes in humans.

Published animal studies have investigated BPC-157 across a range of tissue types — tendon, ligament, muscle, and gastrointestinal tissue — typically as a tool for studying repair and cytoprotection mechanisms.

Researchers often study BPC-157 alongside other repair-associated peptides to compare pathways and effects in the same models.

BPC-157 is supplied as a lyophilized (freeze-dried) powder. Lyophilized peptide is generally stored at -20°C, sealed and protected from light, where it is stable long-term.

For laboratory work it is typically reconstituted with bacteriostatic or sterile water; reconstituted peptide is usually held at 4°C for short-term use or aliquoted and stored at -80°C to preserve stability. Each lot ships with a certificate of analysis documenting HPLC-verified identity and purity.